Safety and Immunogenicity of a Live Recombinant Canarypox Virus Expressing HIV Type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) Followed by a p24E-V3 MN Synthetic Peptide (CLTB-36) Administered in Healthy Volunteers at Low Risk for HIV Infection-Reference-Cited by-同舟云学术

Safety and Immunogenicity of a Live Recombinant Canarypox Virus Expressing HIV Type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) Followed by a p24E-V3 MN Synthetic Peptide (CLTB-36) Administered in Healthy Volunteers at Low Risk for HIV Infection

Published:1999-05 Issue:7 Volume:15 Page:633-645
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Salmon-Ceron Dominique,Excler Jean-Louis,Finkielsztejn Laurent,Autran Brigitte,Gluckman Jean-Claude,Sicard Didier,Matthews Thomas J.,Meignier Bernard,Valentin Christian,Habib Raphaelle El,Blondeau Christine,Raux Maurice,Moog Christiane,Tartaglia James,Chong Pele,Klein Michel,Milcamps Bruno,Heshmati Farad,Plotkin Stanley,Group The Agis,Sida L'Agence Nationale De Recherches Su

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/088922299310935

Reference38 articles.

1. HIV vaccines: where we are and where we are going

2. Neutralizing and Infection-Enhancing Antibody Responses to Human Immunodeficiency Virus Type 1 in Long-Term Nonprogressors

3. A Prime-Boost Approach to HIV Preventive Vaccine Using a Recombinant Canarypox Virus Expressing Glycoprotein 160 (MN) followed by a Recombinant Glycoprotein 160 (MN/LAI)

4. Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV‐1Mngp120, HIV‐1SF2Recombinant gp120, or Both Vaccines in Seronegative Adults

5. HIV Type 1 Vaccine-Induced Cytotoxic T Cell Responses: Potential Role in Vaccine Efficacy

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Bivalent, Chimeric Rabies Virus Expressing Simian Immunodeficiency Virus Envelope Induces Multifunctional Antibody Responses;AIDS Research and Human Retroviruses;2015-11

2. The Evolution of Poxvirus Vaccines;Viruses;2015-04-07

3. Aggregate complexes of HIV-1 induced by multimeric antibodies;Retrovirology;2014-10-02

4. Phase I/II Randomized Trial of Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC-HIV (vCP1452) Prime/LIPO-5 Boost in Healthy, HIV-1-Uninfected Adult Participants;Clinical and Vaccine Immunology;2014-09-24

5. Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV-Exposed Infants in Uganda;JAIDS Journal of Acquired Immune Deficiency Syndromes;2013-05-01